Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The large mucin
CD43
is actively excluded from T cell/APC interaction sites, concentrating in a membrane domain distal to the site of TCR engagement. The cytoplasmic region of
CD43
was necessary and sufficient for this antipodal movement. ERM cytoskeletal adaptor proteins colocalized with
CD43
in this domain. An ERM dominant-negative mutant blocked the distal accumulation of
CD43
and another known ERM binding protein, Rho-GDI. Inhibition of ERM function decreased the production of IL-2 and IFNgamma, without affecting
PKC
(theta) focusing or CD69 upregulation. These results indicate that ERM proteins organize a complex distal to the T cell/APC interaction site and provide evidence that full T cell activation may involve removal of inhibitory proteins from the immunological synapse.
...
PMID:ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. 1172 36
Recognition by T cells of their ligands at the surface of antigen-presenting cells (APCs) leads to T cell activation, polarization of the T cell toward the APC, and formation of an immune synapse. Using ZAP-70-deficient T cells expressing zeta-GFP, we show that ZAP-70 signaling drives the TCR-dependent reorientation of the microtubule-organizing center thus leading to relocation of a zeta-GFP(+) intracellular compartment close to the APC. ZAP-70 is also necessary to supply the synapse with the signaling molecules
PKC
-theta and LAT. In contrast, ZAP-70 is not required for clustering of zeta-GFP and CD2 or exclusion of CD45 and
CD43
from the synapse. These data show that ZAP-70-dependent signaling is required for formation of a functional immune synapse.
...
PMID:In the immune synapse, ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern. 1238 34
CD43
is an abundant cell surface sialoglycoprotein implicated in hemopoietic cell adhesion and activation. Cell stimulation through
CD43
results in recruitment of different signaling proteins, including members of the Src family kinases, Syk, phospholipase Cgamma2, the adapter protein Shc, the guanine nucleotide exchange factor Vav, and activation of
protein kinase C
. In this study, we report that in human T lymphocytes, the zeta-chain is part of the
CD43
signaling pathway. Upon
CD43
engagement, the zeta-chain was tyrosine-phosphorylated, generating docking sites for tyrosine-phosphorylated zeta-associated protein of 70 kDa and Vav. In vitro kinase assays suggested that zeta-associated protein of 70 kDa could account for the kinase activity associated with the zeta-chain following
CD43
engagement. Cross-linking
CD43
on the surface of the Lck-deficient JCaM.1 cells failed to phosphorylate the zeta-chain and associated proteins, suggesting that Lck is a key element in the
CD43
signaling pathway leading to zeta phosphorylation.
CD43
engagement with beads coated with anti-
CD43
mAb resulted in concentration of the zeta-chain toward the bead attachment site, but interestingly, the distribution of the T cell Ag receptor complex remained unaffected. Recruitment of the zeta-chain through
CD43
-mediated signals was not restricted to T lymphocytes because phosphorylation and redistribution of the zeta-chain was also observed in NK cells. Our results provide evidence that the zeta-chain functions as a scaffold molecule in the
CD43
signaling pathway, favoring the recruitment and formation of downstream signaling complexes involved in the
CD43
-mediated cell activation of T lymphocytes and other leukocytes such as NK cells.
...
PMID:The CD43 coreceptor molecule recruits the zeta-chain as part of its signaling pathway. 1290 92
The
CD43
coreceptor molecule has been shown to participate in lymphocyte adhesion and activation. Leukocyte homotypic aggregation results from a cascade of intracellular signals delivered to the cells upon engagement of different cell-surface molecules with their natural ligands. This phenomenon requires an active metabolism, reorganization of the cytoskeleton, and relocalization of cell-surface molecules. The aim of this study was to identify some of the key members of the signaling cascade leading to T lymphocyte homotypic aggregation following
CD43
engagement.
CD43
-mediated homotypic aggregation of T lymphocytes required the participation of Src kinases, phospholipase C-gamma2,
protein kinase C
, phosphatidylinositol-3 kinase, as well as extracellular-regulated kinase 1/2 and p38. Data shown here suggest that these signaling molecules play a central role in regulating actin cytoskeleton remodeling after
CD43
ligation. We also evaluated the ability of immunomodulatory drugs such as leflunomide to block the
CD43
-mediated homotypic aggregation. Leflunomide blocked the recruitment of targets of the Src family kinases as well as actin polymerization, diminishing the ability of T lymphocytes to aggregate in response to
CD43
-specific signals, suggesting that this drug might control the migration and recruitment of lymphoid cells to inflamed tissues.
...
PMID:T cell aggregation induced through CD43: intracellular signals and inhibition by the immunomodulatory drug leflunomide. 1297 8
CD43
down-regulation during the apoptosis of PMN (polymorphonuclear cells) is not caused by proteolysis or internalization. Could it be released with bleb-derived membrane vesicles? Membrane blebbing was followed by microscopy on PMN 'synchronized' by an overnight incubation at 15 degrees C before their spontaneous apoptosis at 37 degrees C. Released vesicles were quantified by flow cytometry. Membrane blebbing, release of bleb-derived membrane vesicles, decrease of
CD43
/CD16 expression and phosphatidylserine externalization occurred simultaneously. However, caspase and
PKC
inhibition prevented annexin binding but not blebbing, vesicle release or
CD43
expression decrease; myosin light chain kinase inhibition prevented cell blebbing and vesicle release but had no effect on
CD43
/CD16 down-regulation or annexin V binding. By electron microscopy,
CD43
appeared poorly expressed on membrane blebs and concentrated at bleb 'necks'. In conclusion,
CD43
down-regulation is not caused by cell blebbing. Cell blebbing, phospholipid 'flip-flop' and
CD43
/CD16 down-regulation are independent membrane events.
...
PMID:Early membrane events in polymorphonuclear cell (PMN) apoptosis: membrane blebbing and vesicle release, CD43 and CD16 down-regulation and phosphatidylserine externalization. 1515 65
The turnover of phosphoinositides leading to
PKC
activation constitutes one of the principal axes of intracellular signaling. In T lymphocytes, the enhanced and prolonged
PKC
activation resulting from the engagement of the TcR and co-receptor molecules ensures a productive T cell response. The
CD43
co-receptor promotes activation and proliferation, by inducing IL-2 secretion and CD69 expression.
CD43
engagement has been shown to promote phosphoinositide turnover and DAG production. Moreover,
PKC
activation was found to be required for the activation of the MAP kinase pathway in response to
CD43
ligation. Here we show that
CD43
engagement led to the membrane translocation and enzymatic activity of specific
PKC
isoenzymes: cPKC (alpha/beta),
nPKC
(epsilon and theta;), aPKC (zeta) and PKCmu. We also show that activation of PKCtheta; resulting from
CD43
ligation induced CD69 expression through an ERK-dependent pathway leading to AP-1, NF-kappaB activation and an ERK independent pathway promoting NFAT activation. Together, these data suggest that PKCtheta; plays a critical role in the co-stimulatory functions of
CD43
in human T cells.
...
PMID:PKCtheta is required for the activation of human T lymphocytes induced by CD43 engagement. 1552 11
Although leukosialin (
CD43
) membrane expression decreases during neutrophil apoptosis, the
CD43
molecule, unexpectedly, is neither proteolyzed nor internalized. We thus wondered whether it could be shed on bleb-derived membrane vesicles. Membrane blebbing is a transient event, hardly appreciated during the asynchronous, spontaneous apoptosis of neutrophils. Cell pre-synchronization at 15 degrees C made it possible to observe numerous blebbing neutrophils for a short 1-h period at 37 degrees C.
CD43
down-regulation co-occurred with the blebbing stage and phosphatidylserine externalization, shortly after mitochondria depolarization and before nuclear condensation. Blebs detaching from the cell body were observed by time lapse fluorescence microscopy, and the release of bleb-derived vesicles was followed by flow cytometry. Phosphatidylserine externalization required caspases and
protein kinase C
(
PKC
) but not the myosin light chain kinase (MLCK). By contrast, bleb formation and release was caspase- and
PKC
-independent but required an active MLCK, whereas
CD43
down-regulation involved caspases but neither
PKC
nor MLCK. Furthermore,
CD43
appeared mostly excluded from membrane blebs by electron microscopy. Thus,
CD43
down-regulation does not result from the release of bleb-derived vesicles. Ultracentrifugation of apoptotic cell supernatants made it possible to recover <1 microM microparticles, which contained the entire
CD43
molecule. These microparticles expressed neutrophil membrane markers such as CD11b, CD66b, and CD63, together with
CD43
. In conclusion, we show that the three early membrane events of apoptosis, namely blebbing, phosphatidylserine externalization, and
CD43
down-regulation, result from different signaling pathways and can occur independently from one another.
CD43
down-regulation results from the shedding of microparticles released during apoptosis but unrelated to the blebbing.
...
PMID:Distinct signaling pathways are involved in leukosialin (CD43) down-regulation, membrane blebbing, and phospholipid scrambling during neutrophil apoptosis. 1557 78
Galectin-1 is a galactoside-binding lectin expressed in multiple tissues that has pleiotropic immunomodulatory functions. We previously showed that galectin-1 activates human monocyte-derived dendritic cells (MDDCs) and triggers a specific genetic program that up-regulates DC migration through the extracellular matrix, an integral property of mucosal DCs. Here, we identify the galectin-1 receptors on MDDCs and immediate downstream effectors of galectin-1-induced MDDC activation and migration. Galectin-1 binding to surface
CD43
and CD45 on MDDCs induced an unusual unipolar co-clustering of these receptors and activates a dose-dependent calcium flux that is abrogated by lactose. Using a kinome screen and a systems biology approach, we identified Syk and
protein kinase C
tyrosine kinases as mediators of the DC activation effects of galectin-1. Galectin-1, but not lipopolysaccharide, stimulated Syk phosphorylation and recruitment of phosphorylated Syk to the
CD43
and CD45 co-cluster on MDDCs. Inhibitors of Syk and
protein kinase C
signaling abrogated galectin-1-induced DC activation as monitored by interleukin-6 production; and MMP-1, -10, and -12 gene up-regulation; and enhanced migration through the extracellular matrix. The latter two are specific features of galectin-1-activated DCs. Interestingly, we also found that galectin-1 can prime DCs to respond more quickly to low dose lipopolysaccharide stimulation. Finally, we underscore the biological relevance of galectin-1-enhanced DC migration by showing that intradermal injection of galectin-1 in MRL-fas mice, which have a defect in skin DC emigration, increased the in vivo migration of dermal DCs to draining lymph nodes.
...
PMID:Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling. 1963 95
<< Previous
1
2
3